Aims: To identify prevalence of psychiatric comorbidity in clinically stable COVID-19 patients.
Materials And Methods: A cross-sectional single point observational study was conducted among clinically stable 72 COVID-19 infected patients. Psychiatric comorbidity was assessed with the help of DSM-5 Self-Rated Level 1 CCSM-Adult scale.